1,246 results on '"Catovsky, Daniel"'
Search Results
2. Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies
3. The Clinical Presentation of CLL
4. The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial
5. Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
6. Etiology and Epidemiology of Chronic Lymphocytic Leukemia
7. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
8. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
9. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
10. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia
11. Supplementary Figures 1-3, Tables 1-3 from Functional Analysis of the ATM-p53-p21 Pathway in the LRF CLL4 Trial: Blockade at the Level of p21 Is Associated with Short Response Duration
12. Long-term follow-up after purine analogue therapy in hairy cell leukaemia
13. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics
14. Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
15. Etiology and Epidemiology of CLL
16. A 3-decade multicenter European experience with cladribine as upfront treatment in 384 hairy cell leukemia patients
17. Etiology and Epidemiology of Chronic Lymphocytic Leukemia
18. CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia
19. Inherited Predisposition to Chronic Lymphocytic Leukemia
20. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
21. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
22. Chlorambucil—Still Not Bad: A Reappraisal
23. Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation
24. The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity
25. The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years
26. An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy
27. Diagnostic issues in chronic lymphocytic leukaemia (CLL)
28. Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies
29. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
30. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia
31. Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis
32. p53 protein overexpression in bone marrow biopsies from chronic lymphocytic leukaemia is associated with TP53 deletion and resistance to fludarabine
33. Familial chronic lymphocytic leukemia
34. Differential diagnosis in chronic lymphocytic leukaemia
35. A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia--susceptibility loci
36. The Association between Deaths Due to Infection and Mutations of the BRAF, FBXW7, NRAS and XPO1 genes: A Report from the LRF CLL4 Trial
37. Telomere Length and CD49d Cooperate with IGHV Gene Status As Predictors of Long-Term Progression-Free Survival in CLL Patients Treated with FCR-Based Regimens
38. Early clinical trials in chronic lymphocytic leukaemia in the UK
39. High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities
40. Etiology and Epidemiology of CLL
41. rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
42. Alemtuzumab in T-cell malignancies
43. Breakpoints in the ataxia telangiectasia gene arise at the RGYW somatic hypermutation motif
44. B-cell prolymphocytic leukemia and hairy cell leukemia: new advances in biology and treatment
45. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma
46. Chronic Lymphocytic Leukaemia and Other B-Cell Disorders
47. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia
48. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia
49. The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma
50. Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.